Prevalence of ocular hemorrhage in patients receiving warfarin therapy

Canadian Journal of Ophthalmology

Volumn 35, Issue 7, 2000, Pages 385-389

  Superstein, R ^a   Gomolin, J E S ^a   Hammouda, W ^a   Rosenberg, A ^a   Overbury, O ^a   Arsenault, C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Complications; Ocular hemorrhage; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHOROID VASCULARIZATION; FEMALE; HUMAN; HYPHEMA; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; VITREOUS HEMORRHAGE;

EID: 0034436432     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(00)80126-X     Document Type: Article

References (20)

1. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range
2. Hemorrhagic complications of anticoagulant treatment
3. Outpatient anticoagulation issues for the primary care physician
4. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
5. Problems associated with long-term anticoagulant therapy
6. Long-term anticoagulant therapy
7. Massive subretinal hemorrhage and anticoagulant therapy
8. Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants
9. Spontaneous hyphema resulting from warfarin
10. Spontaneous hyphaema as a result of systemic anticoagulation in previously abnormal eyes
11. Warfarin, spontaneous hyphaemas, and intraocular lenses
12. Retinopathy in a population-based study
13. Oral anticoagulants
14. Therapeutic ranges for oral anticoagulation in different thromboembolic disorders
15. Guide to anticoagulant therapy: Part 2. Oral anticoagulants
16. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975
17. Risk factors for complications of chronic anticoagulation. A multicenter study
18. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
19. Aging and the anticoagulant response to warfarin therapy
20. Essential hypertension